While many laboratories have reported that cannabinoids induce apoptosis in various tumor subtypes, including astrocytomas, the requirement for CB1 and CB2 in mediating this therapeutic effect has not yet been demonstrated. The gene discussed is CNR2; the disease is astrocytoma (excluding glioblastoma).